Physician profile
Bruce W Johnson
NPI 1619954575
$5,664.02
in general payments reported to CMS, 2019-2025
40 companies · $84.34 in 2025
The $84.34 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $777 · 2020: $584 · 2021: $850 · 2022: $1,462 · 2023: $1,227 · 2024: $679 · 2025: $84.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,991.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,991.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $803.30 | 2019-2024 | |
| Novo Nordisk INC | $722.62 | 2019-2024 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $392.82 | 2021-2025 | |
| Glaxosmithkline, LLC. | $375.63 | 2019-2025 | Shingrix, Arexvy, Boostrix |
| Novartis Pharmaceuticals Corporation | $281.27 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $272.10 | 2019-2024 | Farxiga |
| Astellas Pharma US INC | $271.35 | 2019-2023 | Myrbetriq, Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $260.59 | 2019-2024 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $254.83 | 2019-2023 | Trulance, Xifaxan |
| Abbott Laboratories | $252.82 | 2020-2024 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $247.70 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $242.77 | 2020-2022 | |
| Lilly USA, LLC | $144.25 | 2019-2023 | Mounjaro |
| Amgen INC. | $127.93 | 2019-2023 | Repatha, Otezla |
| Biohaven Pharmaceutical Holding Company LTD. | $98.04 | 2022 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.